2 High Revenue Growth Penny Stocks That Every Investor Should Have On His Watch List!

Aug. 17, 2012 2:50 PM ETMJNA, APDN1 Comment
otcmagic profile picture
otcmagic's Blog
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Contributor Since 2012

stock trader

The first is Medical Marijuana, Inc (PINK: MJNA) which has been making some pretty fantastic announcements as of late. They announced that for the 2nd quarter 2012 they had earnings of $1.47 million on gross revenues of $2.4M representing a 1,200% increase from the 2nd Quarter 2011 when they reported under $200K in revenues.

Numbers such as this are rarely seen on the OTCBB especially for a non reporting pink sheet Company and investors are staying to take interest. In fact, MJNA is quickly building a loyal following of investors that believe this stock is going much, much higher and I am inclined to believe them. Currently trading at just under $0.05 MJNA is making all the right moves and definitely deserves to be on any penny speculators watch list!

The 2nd is Applied DNA Science, Inc (OTC: APDN) a botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.

APDN recently announced its financial results for the third fiscal quarter ending June 30, 2012, generating revenues of $528,574. This represents a revenue increase of 130% from the year before and is higher than their prior record revenue in any complete fiscal year.

The stock has been on the move, trading up in recent sessions from lows of around $0.04 to recent highs of $0.09. Like MJNA, APDN is trading very close to its historical lows and has a lot of potential upside from current levels.

OTCMagic.com is quickly becoming the preeminent destination for up to date information on the hottest stocks in Penny stock World

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.